Back

Pathogenic variants in titin predispose to anthracycline cardiotoxicity: insights from an hiPSC-CM model

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Anticipating risk to protect the heart during cancer treatment Stratification, Prevention and Monitoring ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hanne Boen

University Hospital Antwerp, Edegem (Belgium)

5 More presentations in this session

Presentation thumbnail
Use of direct oral anticoagulants in patients with atrial fibrillation and cancer: a subanalysis of the nationwide Italian START registry
Doctor V. Cormaci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Atorvastatin and left ventricular global longitudinal strain during anthracycline-based chemotherapy
Doctor V. Juhasz (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of anemia on clinical outcomes of active cancer patients with low-risk pulmonary embolism receiving rivaroxaban: insight from the ONCO PE trial
Doctor R. Chatani (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular adverse events in primary lung cancer patients treated with immune checkpoint inhibitors: a nationwide database study
Doctor T. Isawa (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease
Mrs M. Gynnild (Trondheim, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Anticipating risk to protect the heart during cancer treatment
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Genotype-phenotype correlations in patients with titin variants and cardiomyopathy from a Swiss cohort
thumbnail
Congress Presentation
Modulating TTN gene expression in human iPSC-CMs to investigate mechanisms and therapies in TTN-associated dilated cardiomyopathy
thumbnail
Congress Presentation
Titin mediates control of cardiomyocyte proliferation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources